US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 475 actively recruiting studies with Ohio sites out of 475 registered in total. The busiest research areas in Ohio are Ovarian Cancer, Solid Tumor, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, The Cleveland Clinic, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (96), Phase 2 (140), Phase 3 (106), Phase 4 (16).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
475
Recruiting Now
475
← Back to US Map
Top Conditions in Ohio
Ovarian Cancer (9)Solid Tumor (8)Advanced Solid Tumor (8)Heart Failure (7)Colorectal Cancer (7)Prostate Cancer (7)Schizophrenia (7)Acute Myeloid Leukemia (6)Advanced Solid Tumors (6)Chronic Lymphocytic Leukemia (6)Multiple Myeloma (5)Metastatic Castration-resistant Prostate Cancer (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 475 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 475. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Ovarian Cancer, Solid Tumor, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT07086976 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzab...
Condition
Autoimmune Haemolytic Anaemia
Enrollment
90 pts
Location
United States, Argentina, Austria
Sponsor
Sanofi
View Trial →
NCT05298748 N/A
Recruiting
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm In...
Condition
Apnea of Prematurity
Enrollment
34 pts
Location
United States
Sponsor
Case Western Reserve Universit
View Trial →
NCT05701917 N/A
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombos...
Condition
Venous Thromboembolism
Enrollment
300 pts
Location
United States, Austria, Finland
Sponsor
Inari Medical
View Trial →
NCT05565118 Phase 1
Recruiting
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade G...
Condition
High Grade Glioma
Enrollment
10 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT06082947 N/A
Recruiting
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic C...
Condition
Hematopoietic Stem Cell Transplantation
Enrollment
50 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT06917313 Phase 2
Recruiting
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symp...
Condition
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment
92 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07641179 Phase 2
Recruiting
A Study to Evaluate MAR002 for Acromegaly
Condition
Acromegaly
Enrollment
72 pts
Location
United States
Sponsor
Marea Therapeutics
View Trial →
NCT07014917 Phase 2
Recruiting
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
Condition
Chronic Lymphocytic Leukemia
Enrollment
62 pts
Location
United States
Sponsor
Zulfa Omer
View Trial →
NCT07629440 Phase 3
Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Condition
Pneumococcal Disease
Enrollment
3,230 pts
Location
United States, Japan, Puerto Rico
Sponsor
Pfizer
View Trial →
NCT03619850 Phase 3
Recruiting
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmaco...
Condition
Chronic Kidney Disease; Iron Deficiency Anemia
Enrollment
129 pts
Location
United States, Hungary, Lithuania
Sponsor
AMAG Pharmaceuticals, Inc.
View Trial →
NCT03471260 Phase 1, Phase 2
Recruiting
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With ...
Condition
Acute Myeloid Leukemia
Enrollment
96 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06222580 Phase 1
Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Muta...
Condition
Acute Myeloid Leukemia With FLT3/ITD Mutation
Enrollment
30 pts
Location
United States
Sponsor
Uma Borate
View Trial →
NCT07410624 N/A
Recruiting
Augmented Renal Clearance in Neurocritical Care
Condition
TBI (Traumatic Brain Injury)
Enrollment
512 pts
Location
United States, Canada
Sponsor
University of Alberta
View Trial →
NCT05701085 N/A
Recruiting
Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Am...
Condition
Educational Intervention
Enrollment
240 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT07105098 Phase 3
Recruiting
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizoph...
Condition
Schizophrenia
Enrollment
284 pts
Location
United States, Bulgaria, Hungary
Sponsor
Neurocrine Biosciences
View Trial →
NCT06867185 N/A
Recruiting
Evaluating Therapeutic Electrical Stimulation to Improve Nerve Healing After Sur...
Condition
Digital Nerve Injury
Enrollment
60 pts
Location
United States
Sponsor
Checkpoint Surgical Inc.
View Trial →
NCT07089615 N/A
Recruiting
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the P...
Condition
Colonic Polyps
Enrollment
330 pts
Location
United States
Sponsor
Capso Vision, Inc.
View Trial →
NCT07685717 Phase 2
Recruiting
Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leu...
Condition
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrollment
50 pts
Location
United States
Sponsor
Jennifer Woyach
View Trial →
NCT06312176 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combinatio...
Condition
Breast Neoplasms
Enrollment
1,200 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07574593 N/A
Recruiting
NORM-HF Pivotal Study
Condition
Heart Failure
Enrollment
800 pts
Location
United States
Sponsor
Foundry Innovation & Research
View Trial →
NCT07695298 Phase 4
Recruiting
A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neo...
Condition
Presumed Ocular Histoplasmosis
Enrollment
25 pts
Location
United States
Sponsor
Cincinnati Eye Institute, Sout
View Trial →
NCT07723963 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment ...
Condition
Juvenile Myoclonic Epilepsy
Enrollment
260 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT05270733 Phase 4
Recruiting
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcr...
Condition
Psoriasis
Enrollment
56 pts
Location
United States
Sponsor
University Hospitals Cleveland
View Trial →
NCT06030063 N/A
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General A...
Condition
Cesarean Delivery
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Yale University
View Trial →
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
Page 6 of 19 — 475 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology